• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分子成像作为转化乳腺癌科学的一种工具。

Molecular imaging as a tool for translating breast cancer science.

作者信息

Mankoff David A

机构信息

Seattle Cancer Care Alliance and University of Washington, Radiology, Seattle, WA 98109, USA.

出版信息

Breast Cancer Res. 2008;10 Suppl 1(Suppl 1):S3. doi: 10.1186/bcr2126. Epub 2008 Dec 9.

DOI:10.1186/bcr2126
PMID:19091007
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2605100/
Abstract

The ability to measure biochemical and molecular processes underlies progress in breast cancer biology and treatment. These assays have traditionally been performed by analysis of cell culture or tissue samples. More recently, functional and molecular imaging has allowed the in vivo assay of biochemistry and molecular biology, which is highly complementary to tissue-based assays. This review briefly describes different imaging modalities used in molecular imaging and then reviews applications of molecular imaging to breast cancer, with a focus on translational work. It includes sections describing work in functional and physiological tumor imaging, imaging gene product expression, imaging the tumor microenvironment, reporter gene imaging, and cell labeling. Work in both animal models and human is discussed with an eye towards studies that have relevance to breast cancer treatment in patients.

摘要

测量生物化学和分子过程的能力是乳腺癌生物学和治疗取得进展的基础。传统上,这些分析是通过细胞培养或组织样本分析来进行的。最近,功能和分子成像技术使得在体内进行生物化学和分子生物学分析成为可能,这与基于组织的分析具有高度互补性。本文简要介绍了分子成像中使用的不同成像方式,然后回顾了分子成像在乳腺癌中的应用,重点是转化研究。它包括描述功能和生理肿瘤成像、成像基因产物表达、成像肿瘤微环境、报告基因成像和细胞标记的章节。本文讨论了动物模型和人体研究,着眼于与患者乳腺癌治疗相关的研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9030/2605100/f71a18ed3f4c/bcr2126-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9030/2605100/9ddb312e512e/bcr2126-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9030/2605100/f71a18ed3f4c/bcr2126-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9030/2605100/9ddb312e512e/bcr2126-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9030/2605100/f71a18ed3f4c/bcr2126-2.jpg

相似文献

1
Molecular imaging as a tool for translating breast cancer science.分子成像作为转化乳腺癌科学的一种工具。
Breast Cancer Res. 2008;10 Suppl 1(Suppl 1):S3. doi: 10.1186/bcr2126. Epub 2008 Dec 9.
2
Recent advances in imaging endogenous or transferred gene expression utilizing radionuclide technologies in living subjects: applications to breast cancer.利用放射性核素技术在活体受试者中成像内源性或转移基因表达的最新进展:在乳腺癌中的应用
Breast Cancer Res. 2001;3(1):28-35. doi: 10.1186/bcr267. Epub 2000 Dec 11.
3
Multimodality noninvasive imaging of gene transfer using the human sodium iodide symporter.使用人钠碘同向转运体对基因转移进行多模态无创成像。
J Nucl Med. 2004 Mar;45(3):445-9.
4
Molecular Classification of Breast Cancer.乳腺癌的分子分类
PET Clin. 2018 Jul;13(3):325-338. doi: 10.1016/j.cpet.2018.02.004. Epub 2018 May 7.
5
Status of scintimammography and its relationship to other detection methods for breast cancer.
Cancer Biother Radiopharm. 1999 Dec;14(6):435-42. doi: 10.1089/cbr.1999.14.435.
6
How Imaging Can Impact Clinical Trial Design: Molecular Imaging as a Biomarker for Targeted Cancer Therapy.成像如何影响临床试验设计:分子成像作为靶向癌症治疗的生物标志物
Cancer J. 2015 May-Jun;21(3):218-24. doi: 10.1097/PPO.0000000000000116.
7
Imaging mouse cancer models in vivo using reporter transgenes.使用报告基因转基因在体内对小鼠癌症模型进行成像。
Cold Spring Harb Protoc. 2013 Aug 1;2013(8):685-99. doi: 10.1101/pdb.top069864.
8
Breast imaging devices for nuclear medicine.用于核医学的乳腺成像设备。
J Nucl Med Technol. 2012 Jun;40(2):71-8. doi: 10.2967/jnmt.111.097410. Epub 2012 May 4.
9
Molecular imaging: a new way to study molecular processes in vivo.分子成像:一种在体内研究分子过程的新方法。
Mol Cell Endocrinol. 2006 Feb 26;246(1-2):69-75. doi: 10.1016/j.mce.2005.11.013. Epub 2006 Jan 4.
10
Molecular-genetic imaging based on reporter gene expression.基于报告基因表达的分子遗传成像。
J Nucl Med. 2008 Jun;49 Suppl 2:164S-79S. doi: 10.2967/jnumed.107.045955.

引用本文的文献

1
Currents status of radiotracers for breast cancer imaging in PET.正电子发射断层显像(PET)中用于乳腺癌成像的放射性示踪剂的现状。
Transl Oncol. 2025 Mar;53:102304. doi: 10.1016/j.tranon.2025.102304. Epub 2025 Feb 7.
2
Progress and Future Trends in PET/CT and PET/MRI Molecular Imaging Approaches for Breast Cancer.用于乳腺癌的PET/CT和PET/MRI分子成像方法的进展与未来趋势
Front Oncol. 2020 Aug 12;10:1301. doi: 10.3389/fonc.2020.01301. eCollection 2020.
3
Ocular Biodistribution Studies using Molecular Imaging.使用分子成像技术的眼部生物分布研究

本文引用的文献

1
Tumor receptor imaging.肿瘤受体显像
J Nucl Med. 2008 Jun;49 Suppl 2:149S-63S. doi: 10.2967/jnumed.107.045963.
2
Quantitative imaging of estrogen receptor expression in breast cancer with PET and 18F-fluoroestradiol.利用正电子发射断层扫描(PET)和18F-氟雌二醇对乳腺癌中雌激素受体表达进行定量成像。
J Nucl Med. 2008 Mar;49(3):367-74. doi: 10.2967/jnumed.107.047506. Epub 2008 Feb 20.
3
Innovative strategies in in vivo apoptosis imaging.体内细胞凋亡成像的创新策略。
Pharmaceutics. 2019 May 16;11(5):237. doi: 10.3390/pharmaceutics11050237.
4
Ultrasmall targeted nanoparticles with engineered antibody fragments for imaging detection of HER2-overexpressing breast cancer.工程化抗体片段靶向的超小纳米颗粒用于 HER2 过表达乳腺癌的成像检测。
Nat Commun. 2018 Oct 8;9(1):4141. doi: 10.1038/s41467-018-06271-5.
5
[18F]FDG and [18F]FLT PET for the evaluation of response to neo-adjuvant chemotherapy in a model of triple negative breast cancer.[18F]FDG 和 [18F]FLT PET 用于评估三阴性乳腺癌模型中新辅助化疗反应。
PLoS One. 2018 May 23;13(5):e0197754. doi: 10.1371/journal.pone.0197754. eCollection 2018.
6
Conditionally activating optical contrast agent with enhanced sensitivity via gold nanoparticle plasmon energy transfer: feasibility study.通过金纳米粒子等离子体能量转移实现具有增强灵敏度的条件激活光学造影剂:可行性研究
J Nanobiotechnology. 2014 Dec 7;12:56. doi: 10.1186/s12951-014-0056-2.
7
Prospects of nano-material in breast cancer management.纳米材料在乳腺癌管理中的应用前景。
Pathol Oncol Res. 2013 Apr;19(2):155-65. doi: 10.1007/s12253-013-9609-1. Epub 2013 Feb 23.
8
Comparative functional evaluation of immunocompetent mouse breast cancer models established from PyMT-tumors using small animal PET with [(18)F]FDG and [(18)F]FLT.使用小动物PET及[¹⁸F]FDG和[¹⁸F]FLT对源自PyMT肿瘤建立的免疫活性小鼠乳腺癌模型进行比较功能评估。
Am J Nucl Med Mol Imaging. 2012;2(1):88-98. Epub 2011 Dec 15.
9
Multimodality and nanoparticles in medical imaging.医学成像中的多模态和纳米颗粒。
Dalton Trans. 2011 Jun 21;40(23):6087-103. doi: 10.1039/c0dt01656j. Epub 2011 Mar 14.
Curr Med Chem. 2008;15(2):187-94. doi: 10.2174/092986708783330647.
4
Patterns of alphavbeta3 expression in primary and metastatic human breast cancer as shown by 18F-Galacto-RGD PET.18F-半乳糖-RGD PET显示的原发性和转移性人类乳腺癌中αvβ3表达模式。
J Nucl Med. 2008 Feb;49(2):255-9. doi: 10.2967/jnumed.107.045526. Epub 2008 Jan 16.
5
In vivo proton MR spectroscopy of the breast.
Radiographics. 2007 Oct;27 Suppl 1:S253-66. doi: 10.1148/rg.27si075519.
6
Comparison of imaging techniques for tracking cardiac stem cell therapy.用于追踪心脏干细胞治疗的成像技术比较
J Nucl Med. 2007 Dec;48(12):1916-9. doi: 10.2967/jnumed.107.043299.
7
Advances in optical imaging and novel model systems for cancer metastasis research.用于癌症转移研究的光学成像及新型模型系统的进展
Clin Exp Metastasis. 2007;24(8):699-705. doi: 10.1007/s10585-007-9115-5. Epub 2007 Oct 31.
8
Metabolite quantification and high-field MRS in breast cancer.乳腺癌中的代谢物定量分析与高场磁共振波谱分析
NMR Biomed. 2009 Jan;22(1):65-76. doi: 10.1002/nbm.1217.
9
American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer.美国临床肿瘤学会2007年乳腺癌肿瘤标志物应用建议更新版。
J Clin Oncol. 2007 Nov 20;25(33):5287-312. doi: 10.1200/JCO.2007.14.2364. Epub 2007 Oct 22.
10
Inducing and imaging thermal strain using a single ultrasound linear array.使用单个超声线性阵列诱导并成像热应变。
IEEE Trans Ultrason Ferroelectr Freq Control. 2007 Sep;54(9):1718-20. doi: 10.1109/tuffc.2007.454.